Profil

Malvaux Ludovic

See author's contact details
Main Referenced Co-authors
Martial, Joseph  (3)
Struman, Ingrid  (3)
Castermans, Karolien  (2)
Sabatel, Céline  (2)
Tabruyn, Sébastien  (2)
Main Referenced Keywords
Angiogenesis (1); Angiostatic Proteins/*pharmacology (1); Animals (1); Cell Adhesion (1); Clonal Anergy/*drug effects/genetics (1);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (2)
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (4)

Publications (total 4)

The most downloaded
334 downloads
Tabruyn, S., Sabatel, C., Nguyen, N.-Q.-N., Verhaeghe, Castermans, K., Malvaux, L., Griffioen, A. W., Martial, J., & Struman, I. (2007). The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation. Molecular Endocrinology, 21 (6), 1422-9. doi:10.1210/me.2007-0021 https://hdl.handle.net/2268/13844

The most cited

219 citations (Scopus®)

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., LAMBERT, V., Alvarez Gonzalez, M.-L., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (2011). MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells. PLoS ONE, 6 (2), 16979. doi:10.1371/journal.pone.0016979 https://hdl.handle.net/2268/88579

Malvaux, L. (2011). Evidence for a role of microRNA-21 and microRNA-125b in negatively regulating angiogenic processes [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/91595

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., LAMBERT, V., Alvarez Gonzalez, M.-L., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (2011). MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells. PLoS ONE, 6 (2), 16979. doi:10.1371/journal.pone.0016979
Peer Reviewed verified by ORBi

Sabatel, C., Cornet, A., Tabruyn, S., Malvaux, L., Castermans, K., Martial, J., & Struman, I. (2010). Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis. Molecular Cancer, 9 (1), 231. doi:10.1186/1476-4598-9-231
Peer Reviewed verified by ORBi

Tabruyn, S., Sabatel, C., Nguyen, N.-Q.-N., Verhaeghe, Castermans, K., Malvaux, L., Griffioen, A. W., Martial, J., & Struman, I. (2007). The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation. Molecular Endocrinology, 21 (6), 1422-9. doi:10.1210/me.2007-0021
Peer Reviewed verified by ORBi

Contact ORBi